| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1363738 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
SCD1 inhibition may represent a novel treatment for obesity, type-2 diabetes and related metabolic disorders. A prototype thiazole amide analog 13 (MF-152) was identified as an excellent tool in the study of SCD biology in animals.
Graphical abstractA prototype thiazole amide analog 13 (MF-152) was identified as an excellent tool in the study of SCD biology in animals.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Chun Sing Li, Liette Belair, Jocelyne Guay, Renata Murgasva, Wayne Sturkenboom, Yeeman K. Ramtohul, Lei Zhang, Zheng Huang,